Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study.

Men Y, Wang L, Zhang Y, Gao S, Li J, Wu N, Yang B, Liu S, Ren J, Huang Y, Wang D, Liao X, Xing X, Du L, Yang L, Liu Y, Zhang Y, Wei D, Liu Y, Zhang K, Qiao Y, Shi J, Chen W, Dai M, Hui Z.

Front Oncol. 2019 Aug 20;9:786. doi: 10.3389/fonc.2019.00786. eCollection 2019.


Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer.

Bekelman JE, Rosenzweig KE, Bach PB, Schrag D.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):492-9. Epub 2006 Jul 11.


Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S.

Lung Cancer. 2016 Jan;91:41-7. doi: 10.1016/j.lungcan.2015.11.014. Epub 2015 Nov 25.


Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.

Xu Y, Li J, Wang J, Hu X, Ma H, Li P, Zheng X, Chen M.

Oncol Lett. 2018 Feb;15(2):2641-2650. doi: 10.3892/ol.2017.7601. Epub 2017 Dec 13.


Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.

Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB.

Am J Clin Oncol. 2018 Feb;41(2):152-158. doi: 10.1097/COC.0000000000000245.


The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.

Yuan C, Tao X, Zheng D, Pan Y, Ye T, Hu H, Xiang J, Zhang Y, Chen H, Sun Y.

J Surg Oncol. 2019 Mar;119(3):379-387. doi: 10.1002/jso.25308. Epub 2018 Dec 9.


Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.

Wang HH, Deng L, Wen QL, Zhang CZ, Zaorsky NG, Zhang BL, Chen J, Zeng XL, Cui YL, Shi YY, Hou HL, Wang W, Jiang B, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P, Meng MB.

Oncotarget. 2017 May 23;8(38):62998-63013. doi: 10.18632/oncotarget.18071. eCollection 2017 Sep 8.


Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.

Dai H, Hui Z, Ji W, Liang J, Lu J, Ou G, Zhou Z, Feng Q, Xiao Z, Chen D, Zhang H, Yin W, He J, Wang L.

Oncologist. 2011;16(5):641-50. doi: 10.1634/theoncologist.2010-0343. Epub 2011 Apr 11.


Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.

Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA.

J Thorac Oncol. 2015 Jan;10(1):148-55. doi: 10.1097/JTO.0000000000000406.


Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.

Billiet C, De Ruysscher D, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, De Leyn P, Hendrikx M, Bulens P, Le Péchoux C, Mebis J.

J Thorac Oncol. 2016 Sep;11(9):1538-49. doi: 10.1016/j.jtho.2016.05.037. Epub 2016 Jun 30.


Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.

Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB.

J Clin Oncol. 2015 Sep 1;33(25):2727-34. doi: 10.1200/JCO.2015.61.1517. Epub 2015 Jun 22.


Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.

Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.

Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):573-7. doi: 10.1510/icvts.2007.174342. Epub 2008 Apr 15.


Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.

Herskovic A, Mauer E, Christos P, Nagar H.

J Thorac Oncol. 2017 Feb;12(2):302-313. doi: 10.1016/j.jtho.2016.09.135. Epub 2016 Oct 14.


Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer.

Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL.

Adv Radiat Oncol. 2016 Dec 21;2(1):12-18. doi: 10.1016/j.adro.2016.12.004. eCollection 2017 Jan-Mar.


Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.

Péchoux CL, Mercier O, Belemsagha D, Bouaita R, Besse B, Fadel E.

EJC Suppl. 2013 Sep;11(2):123-30. doi: 10.1016/j.ejcsup.2013.07.022. Review.


Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.

Hui Z, Dai H, Liang J, Lv J, Zhou Z, Feng Q, Xiao Z, Chen D, Zhang H, Yin W, Wang L.

Thorac Cancer. 2015 May;6(3):346-53. doi: 10.1111/1759-7714.12186. Epub 2015 Apr 24.


Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer.

Jing X, Meng X, Sun X, Yu J.

Onco Targets Ther. 2016 Feb 19;9:823-31. doi: 10.2147/OTT.S98765. eCollection 2016.

Supplemental Content

Support Center